info icon

This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

Alcohol-induced pseudo-Cushing syndrome

PSEUDOCUSHING

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 E24.4
  • Cause of death: ICD-10 E24.4

2 out of 7 registries used, show all original rules.

12

4. Check minimum number of events

None

12

5. Include endpoints

None

12

6. Filter based on genotype QC (FinnGen only)

12

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
E24
Name in latin
Syndroma pseudo-Cushing alcoholicum

Case counts by codes

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 58 44 13
Only index persons 53 40 13
Unadjusted period prevalence (%)
Whole population 0.00 0.00 0.00
Only index persons 0.00 0.00 0.00
Median age at first event (years)
Whole population 39.17 36.68 47.92
Only index persons 39.21 36.38 47.92

-FinnGen-

Key figures

All Female Male
Number of individuals 12 10 -
Unadjusted period prevalence (%) 0.00 0.00 -
Median age at first event (years) 38.42 36.32 -

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
6
8
13.43
3.52
2.5
1.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
6
18
5.56
2.07
1.2
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
6
20
4.92
1.87
1.3
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
7
32
3.80
1.39
1.4
2.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
5
21
3.33
1.23
2.0
1.6
—
—
—
0
0
(3013512) EKG study
5
22
3.15
1.16
2.0
4.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
5
24
2.83
0.87
2.2
2.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
5
25
2.69
0.85
1.6
1.9
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
12
100
+∞
0.67
14.4
8.8
mmol/l
140.0
139.6
0.30
12
100
(40768797) Stomach Pathology biopsy report
0
20
0.00
0.67
0.0
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
12
101
+∞
0.67
5.5
3.8
mmol/l
1.5
1.6
0.46
12
95
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
0
19
0.00
0.67
0.0
1.2
—
4.1
—
0
10
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
12
98
+∞
0.67
5.1
3.4
mmol/l
1.3
1.1
0.47
12
91
(3015736) pH of Urine
5
34
1.80
0.47
1.8
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
6
81
0.48
0.47
3.7
3.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
12
103
+∞
0.44
15.6
9.9
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
12
103
+∞
0.44
6.4
3.9
mmol/l
2.7
2.8
0.17
12
96
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
12
102
+∞
0.43
5.7
3.6
mmol/l
4.8
4.8
0.09
12
97
(36660697) Celiac disease serology panel - Serum
0
11
0.00
0.22
0.0
1.1
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
12
109
+∞
0.22
16.5
9.6
umol/l
65.8
70.6
0.40
12
109
(3004119) Hemoglobin [Mass/volume] in Venous blood
0
5
0.00
0.00
0.0
1.6
—
124.2
—
0
5
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019225) pH of Specimen
0
6
0.00
0.00
0.0
7.8
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.9
—
109.6
—
0
8
(1002224) Polysomnography panel
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
12
111
+∞
0.00
18.8
14.3
g/l
138.9
136.2
0.37
12
111
(3042936) Bacteria identified in Isolate by Culture
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.6
—
93.8
—
0
5
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
(3002256) Pathology report gross observation
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024731) MCV [Entitic volume]
12
111
+∞
0.00
18.4
14.2
fl
90.8
90.5
0.05
12
111
(3035941) MCH [Entitic mass]
12
111
+∞
0.00
18.3
14.2
pg
30.1
30.2
0.03
12
111
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
5
52
0.93
0.00
11.4
7.3
e9/l
3.3
3.4
—
5
46

Mortality – FinRegistry

Association

Association between endpoint PSEUDOCUSHING and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have PSEUDOCUSHING.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: PSEUDOCUSHING – Alcohol-induced pseudo-Cushing syndrome

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data